Background: Cell therapy approaches for biologic cardiac repair hold great promises, although basic fundamental issues remain poorly understood. In the present study we examined the effects of timing and routes of administration of bone marrow cells (BMC) post-myocardial infarction (MI) and the efficacy of an injectable biopolymer scaffold to improve cardiac cell retention and function. Methodology/Principal Findings: (99m)Tc-labeled BMC (6x10(6) cells) were injected by 4 different routes in adult rats: intravenous (IV), left ventricular cavity (LV), left ventricular cavity with temporal aorta occlusion (LV(+)) to mimic coronary injection, and intramyocardial (IM). The injections were performed 1, 2, 3, or 7 days post-MI and cell retention ...
BACKGROUND: Cardiac cell transplantation is compromised by low cell retention and poor graft viabili...
Kumar, ArunThe burden of cardiovascular disease around the world is growing, despite improvements in...
Implantation of bone marrow-derived cells (BMCs) into mouse hearts post-myocardial infarction (MI) l...
Background: Cell therapy approaches for biologic cardiac repair hold great promises, although basic ...
Bone marrow (BM) stem cells can differentiate into multiple cell types, including vascular cells and...
ObjectivesCell therapy improved cardiac function after a myocardial infarction in several preclinica...
BACKGROUND: Recent studies report that intracoronary administration of autologous bone marrow mononu...
Implantation of bone marrow-derived cells (BMCs) into mouse hearts post-myocardial infarction (MI) l...
International audienceBACKGROUND: To improve the efficacy of bone marrow-derived mesenchymal stem ce...
International audienceABSTRACT : INTRODUCTION : Early randomized clinical trials of autologous bone ...
BACKGROUND Intracoronary administration of autologous bone marrow-derived mononuclear cells (BM-M...
Background: Cardiac cell transplantation is compromised by low cell retention and poor graft viabili...
Background: Since the cell therapy benefits for myocardial infarction are mainly related to infarct ...
The therapeutic effect of mesenchymal stromal cells (MSCs) following myocardial infarction (MI) is s...
AbstractObjectivesBone marrow stromal cells are capable of differentiating into cardiomyogenic cells...
BACKGROUND: Cardiac cell transplantation is compromised by low cell retention and poor graft viabili...
Kumar, ArunThe burden of cardiovascular disease around the world is growing, despite improvements in...
Implantation of bone marrow-derived cells (BMCs) into mouse hearts post-myocardial infarction (MI) l...
Background: Cell therapy approaches for biologic cardiac repair hold great promises, although basic ...
Bone marrow (BM) stem cells can differentiate into multiple cell types, including vascular cells and...
ObjectivesCell therapy improved cardiac function after a myocardial infarction in several preclinica...
BACKGROUND: Recent studies report that intracoronary administration of autologous bone marrow mononu...
Implantation of bone marrow-derived cells (BMCs) into mouse hearts post-myocardial infarction (MI) l...
International audienceBACKGROUND: To improve the efficacy of bone marrow-derived mesenchymal stem ce...
International audienceABSTRACT : INTRODUCTION : Early randomized clinical trials of autologous bone ...
BACKGROUND Intracoronary administration of autologous bone marrow-derived mononuclear cells (BM-M...
Background: Cardiac cell transplantation is compromised by low cell retention and poor graft viabili...
Background: Since the cell therapy benefits for myocardial infarction are mainly related to infarct ...
The therapeutic effect of mesenchymal stromal cells (MSCs) following myocardial infarction (MI) is s...
AbstractObjectivesBone marrow stromal cells are capable of differentiating into cardiomyogenic cells...
BACKGROUND: Cardiac cell transplantation is compromised by low cell retention and poor graft viabili...
Kumar, ArunThe burden of cardiovascular disease around the world is growing, despite improvements in...
Implantation of bone marrow-derived cells (BMCs) into mouse hearts post-myocardial infarction (MI) l...